Biomarkers Conference (Biomarkers)

Venue: BSG House

Location: London, United Kingdom

Event Date/Time: Mar 16, 2009 End Date/Time: Mar 18, 2009
Report as Spam


"Market for biomarkers and related tests was worth approximately $11 billion in 2008 and this figure will expand to $19 billion by 2013" - Jain PharmaBiotech 2009

The development and application of biomarkers have become an increasingly important topic for the pharma/biotech companies.

Biomarkers are not only used as the valuable tools in the early development stages in the lifecycle of a new drug but they also play a significant role after the drug is introduced in the market.

Our 2nd Annual Biomarkers Conference will provide an ideal platform for the attendees to get an overview of the biomarkers. This conference will enable you to identify and overcome the challenges in the specific therapeutic areas and understand the new developments and recent advancements in the field of biomarkers.

Reasons for attending the Conference:
• Share and discuss the growth trends in the biomarkers
• Get timely answers to the key questions about the role of biomarkers in drug development and clinical use
• Identify the challenges in the specific therapeutic areas
• Examine the biomarker data management and analysis
• Understand the recent advancement in imaging modalities as biomarkers
• Hear about the effective biomarker out- and in-licensing
• Gain an insight into the commercial aspects in biomarkers
• Discuss the latest biomarker assay developments and methods of clinical validation

Key Speakers
• Dr Michael Binks, Head, Immuno-Epigenetics DPU Immuno-Infl ammation CEDD, GlaxoSmithKline
• Eugenii A (Ilan) Rabiner, Director, Clinical Imaging Applications, GlaxoSmithKline
• Magnus Ivarsson, Team Leader in the Biomarker group, Pfi zer
• Simon Read, Leader Biomarker and Experimental Medicine, Roche
• Dr Jochen Theis, Owner and Principle Consultant, InHeCon Jochen Theis
• Dr Richard Kennedy, Vice President of Translational Research and Development, Almac Diagnostics
• Dr Christian Czech, CNS Research, Roche
• Dr Oliver Steinbach, Senior Director, Department Bio-Molecular Engineering, Philips Research
• Dr Eddie Blair, Director, Integrated Medicines
• Dr Timothy Ebbels, Lecturer in Computational Bioinformatics, Imperial College London
• Dr Manuel Mayr, Lecturer, Cardiovascular Division, Kings College London
• Dr Elke Roschmann, Senior Director Strategic Development & Licensing, Epidauros Biotechnologie
• Prof K. K. Jain, CEO, PharmaBiotech

Who will be there?
VPs, Directors, Heads and Managers of:
• Biomarker Development Programmes
• Clinical Pharmacology
• Clinical Research
• Drug Discovery and Development
• Alliance Management
• Safety Assessment
• Assay Development
• Proteomics/ Genomics Programmes
• Regulatory Affairs
• Translational Medicine
• Oncology
• Inflammation and Immunology
• Biological Sciences
• Marketing
• Product
• Diagnostics
• Bioanalysis
• Pharmacokinetics & Drug Metabolism
• Genomics Business Development
• Strategic Alliances
• Cellular & Molecular Dev
• Clinical Discovery Technologies
• Pharmacogenomics & Human Genetics
• Discovery Research
• Bioengineering


BSG House
226-236 City Road
United Kingdom

Additional Information

Standard Prices : Conference and workshop Fee: £1699 VAT: £254.85 Total: £1953.85 Conference only Fee: £1299 VAT: £194.85 Total: £1493.85 Workshop only Fee: £599 VAT: £89.85 Total: £688.85 Promotional Literature Distribution Distribution of your company’s promotional literature to all conference attendees Fee: £999 VAT: £149.85 Total: £1148.85